nodes	percent_of_prediction	percent_of_DWPC	metapath
Procaine—Meningism—Thiotepa—sarcoma	0.0768	0.0811	CcSEcCtD
Procaine—Respiratory arrest—Thiotepa—sarcoma	0.0303	0.032	CcSEcCtD
Procaine—Eruption—Dactinomycin—sarcoma	0.0215	0.0227	CcSEcCtD
Procaine—Nephropathy—Etoposide—sarcoma	0.0201	0.0212	CcSEcCtD
Procaine—Paralysis—Vincristine—sarcoma	0.017	0.018	CcSEcCtD
Procaine—BCHE—diaphragm—sarcoma	0.0157	0.296	CbGeAlD
Procaine—Apnoea—Etoposide—sarcoma	0.0113	0.0119	CcSEcCtD
Procaine—Neuropathy—Vincristine—sarcoma	0.0111	0.0117	CcSEcCtD
Procaine—Cardiac arrest—Thiotepa—sarcoma	0.0092	0.00971	CcSEcCtD
Procaine—Neuropathy—Etoposide—sarcoma	0.00899	0.00949	CcSEcCtD
Procaine—Eruption—Epirubicin—sarcoma	0.00872	0.00921	CcSEcCtD
Procaine—Anaphylactoid reaction—Mitoxantrone—sarcoma	0.00863	0.00911	CcSEcCtD
Procaine—Cardiac arrest—Vincristine—sarcoma	0.00816	0.00861	CcSEcCtD
Procaine—Eruption—Doxorubicin—sarcoma	0.00807	0.00852	CcSEcCtD
Procaine—Paralysis—Epirubicin—sarcoma	0.00772	0.00815	CcSEcCtD
Procaine—Ventricular arrhythmia—Epirubicin—sarcoma	0.00725	0.00765	CcSEcCtD
Procaine—Anaphylactoid reaction—Etoposide—sarcoma	0.00718	0.00758	CcSEcCtD
Procaine—Paralysis—Doxorubicin—sarcoma	0.00715	0.00755	CcSEcCtD
Procaine—Sweating increased—Mitoxantrone—sarcoma	0.00703	0.00743	CcSEcCtD
Procaine—CHRNA2—mammary gland—sarcoma	0.00676	0.128	CbGeAlD
Procaine—Ventricular arrhythmia—Doxorubicin—sarcoma	0.00671	0.00708	CcSEcCtD
Procaine—Hallucination—Thiotepa—sarcoma	0.00666	0.00703	CcSEcCtD
Procaine—Cardiac arrest—Etoposide—sarcoma	0.00661	0.00698	CcSEcCtD
Procaine—Neuropathy peripheral—Vincristine—sarcoma	0.00648	0.00684	CcSEcCtD
Procaine—Drowsiness—Mitoxantrone—sarcoma	0.00644	0.0068	CcSEcCtD
Procaine—Tinnitus—Thiotepa—sarcoma	0.00624	0.00659	CcSEcCtD
Procaine—Vasodilation—Epirubicin—sarcoma	0.00611	0.00645	CcSEcCtD
Procaine—Vasodilation procedure—Epirubicin—sarcoma	0.00611	0.00645	CcSEcCtD
Procaine—Chills—Thiotepa—sarcoma	0.006	0.00634	CcSEcCtD
Procaine—Chills—Dactinomycin—sarcoma	0.00596	0.00629	CcSEcCtD
Procaine—Hallucination—Vincristine—sarcoma	0.0059	0.00623	CcSEcCtD
Procaine—Bradycardia—Mitoxantrone—sarcoma	0.00588	0.00621	CcSEcCtD
Procaine—Sweating increased—Etoposide—sarcoma	0.00585	0.00618	CcSEcCtD
Procaine—Erythema—Thiotepa—sarcoma	0.00583	0.00615	CcSEcCtD
Procaine—Erythema—Dactinomycin—sarcoma	0.00578	0.0061	CcSEcCtD
Procaine—Tension—Thiotepa—sarcoma	0.00572	0.00604	CcSEcCtD
Procaine—Nervousness—Thiotepa—sarcoma	0.00566	0.00597	CcSEcCtD
Procaine—Vasodilation—Doxorubicin—sarcoma	0.00565	0.00597	CcSEcCtD
Procaine—Vasodilation procedure—Doxorubicin—sarcoma	0.00565	0.00597	CcSEcCtD
Procaine—Atrioventricular block—Epirubicin—sarcoma	0.00553	0.00584	CcSEcCtD
Procaine—Vision blurred—Thiotepa—sarcoma	0.00549	0.0058	CcSEcCtD
Procaine—Agitation—Thiotepa—sarcoma	0.00535	0.00565	CcSEcCtD
Procaine—Neuropathy peripheral—Etoposide—sarcoma	0.00525	0.00554	CcSEcCtD
Procaine—Leukopenia—Thiotepa—sarcoma	0.00521	0.00551	CcSEcCtD
Procaine—Chills—Mitoxantrone—sarcoma	0.00519	0.00547	CcSEcCtD
Procaine—Leukopenia—Dactinomycin—sarcoma	0.00518	0.00546	CcSEcCtD
Procaine—Atrioventricular block—Doxorubicin—sarcoma	0.00512	0.0054	CcSEcCtD
Procaine—Convulsion—Thiotepa—sarcoma	0.00505	0.00533	CcSEcCtD
Procaine—Neuropathy—Epirubicin—sarcoma	0.00504	0.00532	CcSEcCtD
Procaine—Erythema—Mitoxantrone—sarcoma	0.00503	0.00531	CcSEcCtD
Procaine—Hypertension—Thiotepa—sarcoma	0.00503	0.00531	CcSEcCtD
Procaine—Arthralgia—Thiotepa—sarcoma	0.00496	0.00524	CcSEcCtD
Procaine—Anxiety—Thiotepa—sarcoma	0.00494	0.00522	CcSEcCtD
Procaine—Agitation—Vincristine—sarcoma	0.00475	0.00501	CcSEcCtD
Procaine—Vision blurred—Mitoxantrone—sarcoma	0.00474	0.00501	CcSEcCtD
Procaine—Oedema—Dactinomycin—sarcoma	0.00472	0.00498	CcSEcCtD
Procaine—Neuropathy—Doxorubicin—sarcoma	0.00466	0.00492	CcSEcCtD
Procaine—Thrombocytopenia—Thiotepa—sarcoma	0.00465	0.00492	CcSEcCtD
Procaine—Tachycardia—Thiotepa—sarcoma	0.00464	0.0049	CcSEcCtD
Procaine—Leukopenia—Vincristine—sarcoma	0.00462	0.00488	CcSEcCtD
Procaine—Thrombocytopenia—Dactinomycin—sarcoma	0.00462	0.00488	CcSEcCtD
Procaine—Leukopenia—Mitoxantrone—sarcoma	0.0045	0.00475	CcSEcCtD
Procaine—Convulsion—Vincristine—sarcoma	0.00448	0.00473	CcSEcCtD
Procaine—Hypertension—Vincristine—sarcoma	0.00446	0.00471	CcSEcCtD
Procaine—Convulsion—Mitoxantrone—sarcoma	0.00436	0.0046	CcSEcCtD
Procaine—Hypertension—Mitoxantrone—sarcoma	0.00434	0.00459	CcSEcCtD
Procaine—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00433	0.00457	CcSEcCtD
Procaine—Chills—Etoposide—sarcoma	0.00431	0.00455	CcSEcCtD
Procaine—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.0043	0.00454	CcSEcCtD
Procaine—Arthralgia—Mitoxantrone—sarcoma	0.00428	0.00452	CcSEcCtD
Procaine—Anxiety—Mitoxantrone—sarcoma	0.00427	0.00451	CcSEcCtD
Procaine—Somnolence—Thiotepa—sarcoma	0.00423	0.00446	CcSEcCtD
Procaine—Oedema—Vincristine—sarcoma	0.00422	0.00445	CcSEcCtD
Procaine—Anaphylactic shock—Vincristine—sarcoma	0.00422	0.00445	CcSEcCtD
Procaine—Dermatitis exfoliative—Epirubicin—sarcoma	0.00413	0.00436	CcSEcCtD
Procaine—Thrombocytopenia—Vincristine—sarcoma	0.00413	0.00436	CcSEcCtD
Procaine—Oedema—Mitoxantrone—sarcoma	0.00411	0.00434	CcSEcCtD
Procaine—Anaphylactic shock—Mitoxantrone—sarcoma	0.00411	0.00434	CcSEcCtD
Procaine—Fatigue—Thiotepa—sarcoma	0.0041	0.00433	CcSEcCtD
Procaine—Hyperhidrosis—Vincristine—sarcoma	0.00408	0.0043	CcSEcCtD
Procaine—Fatigue—Dactinomycin—sarcoma	0.00407	0.0043	CcSEcCtD
Procaine—Shock—Mitoxantrone—sarcoma	0.00404	0.00427	CcSEcCtD
Procaine—Anaphylactoid reaction—Epirubicin—sarcoma	0.00402	0.00425	CcSEcCtD
Procaine—Thrombocytopenia—Mitoxantrone—sarcoma	0.00402	0.00424	CcSEcCtD
Procaine—Tachycardia—Mitoxantrone—sarcoma	0.00401	0.00423	CcSEcCtD
Procaine—Hyperhidrosis—Mitoxantrone—sarcoma	0.00397	0.00419	CcSEcCtD
Procaine—Hypotension—Vincristine—sarcoma	0.00394	0.00416	CcSEcCtD
Procaine—Musculoskeletal discomfort—Vincristine—sarcoma	0.00384	0.00406	CcSEcCtD
Procaine—Hypotension—Mitoxantrone—sarcoma	0.00384	0.00405	CcSEcCtD
Procaine—Dermatitis exfoliative—Doxorubicin—sarcoma	0.00382	0.00403	CcSEcCtD
Procaine—Urticaria—Thiotepa—sarcoma	0.00378	0.00399	CcSEcCtD
Procaine—Body temperature increased—Thiotepa—sarcoma	0.00376	0.00397	CcSEcCtD
Procaine—Leukopenia—Etoposide—sarcoma	0.00375	0.00395	CcSEcCtD
Procaine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00374	0.00395	CcSEcCtD
Procaine—Body temperature increased—Dactinomycin—sarcoma	0.00373	0.00394	CcSEcCtD
Procaine—Anaphylactoid reaction—Doxorubicin—sarcoma	0.00372	0.00393	CcSEcCtD
Procaine—Cardiac arrest—Epirubicin—sarcoma	0.0037	0.00391	CcSEcCtD
Procaine—Loss of consciousness—Etoposide—sarcoma	0.00368	0.00388	CcSEcCtD
Procaine—Somnolence—Mitoxantrone—sarcoma	0.00365	0.00385	CcSEcCtD
Procaine—Fatigue—Vincristine—sarcoma	0.00363	0.00384	CcSEcCtD
Procaine—Convulsion—Etoposide—sarcoma	0.00363	0.00383	CcSEcCtD
Procaine—Hypertension—Etoposide—sarcoma	0.00361	0.00381	CcSEcCtD
Procaine—Fatigue—Mitoxantrone—sarcoma	0.00354	0.00374	CcSEcCtD
Procaine—Hypersensitivity—Thiotepa—sarcoma	0.0035	0.0037	CcSEcCtD
Procaine—Hypersensitivity—Dactinomycin—sarcoma	0.00348	0.00367	CcSEcCtD
Procaine—Cardiac arrest—Doxorubicin—sarcoma	0.00343	0.00362	CcSEcCtD
Procaine—Anaphylactic shock—Etoposide—sarcoma	0.00341	0.00361	CcSEcCtD
Procaine—Pruritus—Thiotepa—sarcoma	0.00336	0.00355	CcSEcCtD
Procaine—Thrombocytopenia—Etoposide—sarcoma	0.00334	0.00353	CcSEcCtD
Procaine—Tachycardia—Etoposide—sarcoma	0.00333	0.00352	CcSEcCtD
Procaine—Eosinophilia—Epirubicin—sarcoma	0.00333	0.00352	CcSEcCtD
Procaine—Body temperature increased—Vincristine—sarcoma	0.00333	0.00352	CcSEcCtD
Procaine—Hyperhidrosis—Etoposide—sarcoma	0.0033	0.00349	CcSEcCtD
Procaine—Urticaria—Mitoxantrone—sarcoma	0.00326	0.00344	CcSEcCtD
Procaine—Diarrhoea—Thiotepa—sarcoma	0.00325	0.00343	CcSEcCtD
Procaine—Body temperature increased—Mitoxantrone—sarcoma	0.00325	0.00343	CcSEcCtD
Procaine—Diarrhoea—Dactinomycin—sarcoma	0.00323	0.00341	CcSEcCtD
Procaine—Hypotension—Etoposide—sarcoma	0.00319	0.00337	CcSEcCtD
Procaine—SCN10A—hematopoietic system—sarcoma	0.00318	0.06	CbGeAlD
Procaine—Dizziness—Thiotepa—sarcoma	0.00314	0.00332	CcSEcCtD
Procaine—Hypersensitivity—Vincristine—sarcoma	0.00311	0.00328	CcSEcCtD
Procaine—Eosinophilia—Doxorubicin—sarcoma	0.00308	0.00326	CcSEcCtD
Procaine—GRIN3A—testis—sarcoma	0.00308	0.0582	CbGeAlD
Procaine—Somnolence—Etoposide—sarcoma	0.00304	0.00321	CcSEcCtD
Procaine—Hypersensitivity—Mitoxantrone—sarcoma	0.00302	0.00319	CcSEcCtD
Procaine—Vomiting—Thiotepa—sarcoma	0.00302	0.00319	CcSEcCtD
Procaine—Drowsiness—Epirubicin—sarcoma	0.003	0.00317	CcSEcCtD
Procaine—Vomiting—Dactinomycin—sarcoma	0.003	0.00317	CcSEcCtD
Procaine—Rash—Thiotepa—sarcoma	0.003	0.00317	CcSEcCtD
Procaine—Dermatitis—Thiotepa—sarcoma	0.00299	0.00316	CcSEcCtD
Procaine—Rash—Dactinomycin—sarcoma	0.00298	0.00314	CcSEcCtD
Procaine—HTR3A—hematopoietic system—sarcoma	0.00295	0.0556	CbGeAlD
Procaine—Fatigue—Etoposide—sarcoma	0.00294	0.00311	CcSEcCtD
Procaine—Neuropathy peripheral—Epirubicin—sarcoma	0.00294	0.00311	CcSEcCtD
Procaine—Diarrhoea—Vincristine—sarcoma	0.00288	0.00305	CcSEcCtD
Procaine—Nausea—Thiotepa—sarcoma	0.00282	0.00298	CcSEcCtD
Procaine—Diarrhoea—Mitoxantrone—sarcoma	0.00281	0.00297	CcSEcCtD
Procaine—Nausea—Dactinomycin—sarcoma	0.0028	0.00296	CcSEcCtD
Procaine—Dizziness—Vincristine—sarcoma	0.00279	0.00294	CcSEcCtD
Procaine—Drowsiness—Doxorubicin—sarcoma	0.00278	0.00293	CcSEcCtD
Procaine—Bradycardia—Epirubicin—sarcoma	0.00274	0.0029	CcSEcCtD
Procaine—Neuropathy peripheral—Doxorubicin—sarcoma	0.00272	0.00287	CcSEcCtD
Procaine—Urticaria—Etoposide—sarcoma	0.00271	0.00286	CcSEcCtD
Procaine—Body temperature increased—Etoposide—sarcoma	0.0027	0.00285	CcSEcCtD
Procaine—Vomiting—Vincristine—sarcoma	0.00268	0.00283	CcSEcCtD
Procaine—Rash—Vincristine—sarcoma	0.00266	0.00281	CcSEcCtD
Procaine—Dermatitis—Vincristine—sarcoma	0.00266	0.0028	CcSEcCtD
Procaine—Vomiting—Mitoxantrone—sarcoma	0.00261	0.00276	CcSEcCtD
Procaine—Rash—Mitoxantrone—sarcoma	0.00259	0.00273	CcSEcCtD
Procaine—Dermatitis—Mitoxantrone—sarcoma	0.00259	0.00273	CcSEcCtD
Procaine—Bradycardia—Doxorubicin—sarcoma	0.00254	0.00268	CcSEcCtD
Procaine—Hypersensitivity—Etoposide—sarcoma	0.00252	0.00266	CcSEcCtD
Procaine—Tinnitus—Epirubicin—sarcoma	0.00251	0.00265	CcSEcCtD
Procaine—Nausea—Vincristine—sarcoma	0.0025	0.00264	CcSEcCtD
Procaine—SLC6A3—hematopoietic system—sarcoma	0.00245	0.0463	CbGeAlD
Procaine—Nausea—Mitoxantrone—sarcoma	0.00244	0.00257	CcSEcCtD
Procaine—Chills—Epirubicin—sarcoma	0.00242	0.00255	CcSEcCtD
Procaine—Pruritus—Etoposide—sarcoma	0.00242	0.00255	CcSEcCtD
Procaine—Erythema—Epirubicin—sarcoma	0.00235	0.00248	CcSEcCtD
Procaine—Diarrhoea—Etoposide—sarcoma	0.00234	0.00247	CcSEcCtD
Procaine—Tinnitus—Doxorubicin—sarcoma	0.00232	0.00245	CcSEcCtD
Procaine—Tension—Epirubicin—sarcoma	0.0023	0.00243	CcSEcCtD
Procaine—Nervousness—Epirubicin—sarcoma	0.00228	0.00241	CcSEcCtD
Procaine—Dizziness—Etoposide—sarcoma	0.00226	0.00238	CcSEcCtD
Procaine—Chills—Doxorubicin—sarcoma	0.00224	0.00236	CcSEcCtD
Procaine—SCN10A—lymphoid tissue—sarcoma	0.00224	0.0423	CbGeAlD
Procaine—Vision blurred—Epirubicin—sarcoma	0.00221	0.00233	CcSEcCtD
Procaine—Vomiting—Etoposide—sarcoma	0.00217	0.00229	CcSEcCtD
Procaine—Erythema—Doxorubicin—sarcoma	0.00217	0.00229	CcSEcCtD
Procaine—Agitation—Epirubicin—sarcoma	0.00216	0.00228	CcSEcCtD
Procaine—Rash—Etoposide—sarcoma	0.00215	0.00227	CcSEcCtD
Procaine—Dermatitis—Etoposide—sarcoma	0.00215	0.00227	CcSEcCtD
Procaine—Tension—Doxorubicin—sarcoma	0.00213	0.00225	CcSEcCtD
Procaine—Nervousness—Doxorubicin—sarcoma	0.00211	0.00223	CcSEcCtD
Procaine—Syncope—Epirubicin—sarcoma	0.0021	0.00222	CcSEcCtD
Procaine—Leukopenia—Epirubicin—sarcoma	0.0021	0.00222	CcSEcCtD
Procaine—Loss of consciousness—Epirubicin—sarcoma	0.00206	0.00218	CcSEcCtD
Procaine—Vision blurred—Doxorubicin—sarcoma	0.00205	0.00216	CcSEcCtD
Procaine—Convulsion—Epirubicin—sarcoma	0.00203	0.00215	CcSEcCtD
Procaine—Nausea—Etoposide—sarcoma	0.00203	0.00214	CcSEcCtD
Procaine—Hypertension—Epirubicin—sarcoma	0.00203	0.00214	CcSEcCtD
Procaine—Arthralgia—Epirubicin—sarcoma	0.002	0.00211	CcSEcCtD
Procaine—Agitation—Doxorubicin—sarcoma	0.00199	0.00211	CcSEcCtD
Procaine—Anxiety—Epirubicin—sarcoma	0.00199	0.0021	CcSEcCtD
Procaine—Syncope—Doxorubicin—sarcoma	0.00195	0.00206	CcSEcCtD
Procaine—Leukopenia—Doxorubicin—sarcoma	0.00194	0.00205	CcSEcCtD
Procaine—Oedema—Epirubicin—sarcoma	0.00191	0.00202	CcSEcCtD
Procaine—Anaphylactic shock—Epirubicin—sarcoma	0.00191	0.00202	CcSEcCtD
Procaine—Loss of consciousness—Doxorubicin—sarcoma	0.00191	0.00201	CcSEcCtD
Procaine—BCHE—myometrium—sarcoma	0.0019	0.036	CbGeAlD
Procaine—Shock—Epirubicin—sarcoma	0.00188	0.00199	CcSEcCtD
Procaine—Convulsion—Doxorubicin—sarcoma	0.00188	0.00199	CcSEcCtD
Procaine—Thrombocytopenia—Epirubicin—sarcoma	0.00187	0.00198	CcSEcCtD
Procaine—Hypertension—Doxorubicin—sarcoma	0.00187	0.00198	CcSEcCtD
Procaine—Tachycardia—Epirubicin—sarcoma	0.00187	0.00197	CcSEcCtD
Procaine—Hyperhidrosis—Epirubicin—sarcoma	0.00185	0.00195	CcSEcCtD
Procaine—Arthralgia—Doxorubicin—sarcoma	0.00185	0.00195	CcSEcCtD
Procaine—Anxiety—Doxorubicin—sarcoma	0.00184	0.00194	CcSEcCtD
Procaine—Hypotension—Epirubicin—sarcoma	0.00179	0.00189	CcSEcCtD
Procaine—Anaphylactic shock—Doxorubicin—sarcoma	0.00177	0.00187	CcSEcCtD
Procaine—Oedema—Doxorubicin—sarcoma	0.00177	0.00187	CcSEcCtD
Procaine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00174	0.00184	CcSEcCtD
Procaine—Shock—Doxorubicin—sarcoma	0.00174	0.00184	CcSEcCtD
Procaine—Thrombocytopenia—Doxorubicin—sarcoma	0.00173	0.00183	CcSEcCtD
Procaine—Tachycardia—Doxorubicin—sarcoma	0.00173	0.00183	CcSEcCtD
Procaine—BCHE—seminal vesicle—sarcoma	0.00172	0.0325	CbGeAlD
Procaine—Hyperhidrosis—Doxorubicin—sarcoma	0.00171	0.00181	CcSEcCtD
Procaine—Somnolence—Epirubicin—sarcoma	0.0017	0.0018	CcSEcCtD
Procaine—Hypotension—Doxorubicin—sarcoma	0.00166	0.00175	CcSEcCtD
Procaine—Fatigue—Epirubicin—sarcoma	0.00165	0.00174	CcSEcCtD
Procaine—BCHE—hematopoietic system—sarcoma	0.00163	0.0309	CbGeAlD
Procaine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00161	0.0017	CcSEcCtD
Procaine—Somnolence—Doxorubicin—sarcoma	0.00157	0.00166	CcSEcCtD
Procaine—Fatigue—Doxorubicin—sarcoma	0.00153	0.00161	CcSEcCtD
Procaine—Urticaria—Epirubicin—sarcoma	0.00152	0.00161	CcSEcCtD
Procaine—Body temperature increased—Epirubicin—sarcoma	0.00151	0.0016	CcSEcCtD
Procaine—BCHE—smooth muscle tissue—sarcoma	0.00144	0.0272	CbGeAlD
Procaine—BCHE—skin of body—sarcoma	0.00142	0.0268	CbGeAlD
Procaine—Hypersensitivity—Epirubicin—sarcoma	0.00141	0.00149	CcSEcCtD
Procaine—Urticaria—Doxorubicin—sarcoma	0.00141	0.00149	CcSEcCtD
Procaine—Body temperature increased—Doxorubicin—sarcoma	0.0014	0.00148	CcSEcCtD
Procaine—Pruritus—Epirubicin—sarcoma	0.00135	0.00143	CcSEcCtD
Procaine—SLC6A3—testis—sarcoma	0.00134	0.0254	CbGeAlD
Procaine—Diarrhoea—Epirubicin—sarcoma	0.00131	0.00138	CcSEcCtD
Procaine—Hypersensitivity—Doxorubicin—sarcoma	0.0013	0.00138	CcSEcCtD
Procaine—Dizziness—Epirubicin—sarcoma	0.00127	0.00134	CcSEcCtD
Procaine—SCN10A—lymph node—sarcoma	0.00126	0.0238	CbGeAlD
Procaine—Pruritus—Doxorubicin—sarcoma	0.00125	0.00132	CcSEcCtD
Procaine—BCHE—cardiac atrium—sarcoma	0.00124	0.0234	CbGeAlD
Procaine—BCHE—uterus—sarcoma	0.00123	0.0233	CbGeAlD
Procaine—Vomiting—Epirubicin—sarcoma	0.00122	0.00129	CcSEcCtD
Procaine—Diarrhoea—Doxorubicin—sarcoma	0.00121	0.00128	CcSEcCtD
Procaine—Rash—Epirubicin—sarcoma	0.00121	0.00127	CcSEcCtD
Procaine—Dermatitis—Epirubicin—sarcoma	0.00121	0.00127	CcSEcCtD
Procaine—Dizziness—Doxorubicin—sarcoma	0.00117	0.00124	CcSEcCtD
Procaine—Nausea—Epirubicin—sarcoma	0.00114	0.0012	CcSEcCtD
Procaine—Vomiting—Doxorubicin—sarcoma	0.00113	0.00119	CcSEcCtD
Procaine—Rash—Doxorubicin—sarcoma	0.00112	0.00118	CcSEcCtD
Procaine—Dermatitis—Doxorubicin—sarcoma	0.00112	0.00118	CcSEcCtD
Procaine—Nausea—Doxorubicin—sarcoma	0.00105	0.00111	CcSEcCtD
Procaine—BCHE—bone marrow—sarcoma	0.00105	0.0198	CbGeAlD
Procaine—BCHE—testis—sarcoma	0.000896	0.0169	CbGeAlD
Procaine—BCHE—liver—sarcoma	0.000847	0.016	CbGeAlD
Procaine—BCHE—lymph node—sarcoma	0.000649	0.0123	CbGeAlD
